Holen Sie sich die Stockscreener-App
32.97
1.52%
-0.7107
Viking Therapeutics Inc Aktie (VKTX) Neueste Nachrichten
Viking Therapeutics, Inc. (VKTX) Stock Price, News, Quote & History - Yahoo Finance
NFLX: Netflix Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Novo Nordisk's Semaglutide Meets Goal in Pediatric Obesity Study - Zacks Investment Research
Kuehn Law Encourages Investors of Viking Therapeutics, Inc. to Contact Law Firm - Eastern Progress
Viking Therapeutics Moves Closer To Challenging Ozempic With Phase 3 Trial Progress - Stocktwits
VKTX Stock Rallies After Hours On Optimism Around Company’s Obesity Pipeline - Stocktwits
VKTX Stock On Track For Five Consecutive Days Of Gains — Viking Launches Human Trial For Novel Obesity Drug VK3019 - Stocktwits
VKTX Stock Has Nearly 300% Wall Street Upside — Is Viking’s Oral Obesity Pill The Next Novo Nordisk-Style Breakout? - Stocktwits
Viking Therapeutics Trades Well Below Its Wall Street Targets. Here's the Skeptics' Case. - The Motley Fool
VKTX Stock Edges Higher In August Ahead Of Early-Stage Obesity-Drug Data Release In Q3 - Stocktwits
LLY, NVO Stocks Led May’s GLP-1 Rally — But This Smaller ‘Differentiated Player’ Got A Bold 160% Upside Call - Stocktwits
Is Viking Therapeutics (VKTX) Stock Fully Priced After A 411% Run? - Yahoo! Finance Canada
Viking Therapeutics Inc. (VKTX) Peer Comparison – Compare with Others - Value Research
VKTX Stock Price, Quote & Chart - ChartMill
Viking Therapeutics, Inc. (VKTX) Outperforms Broader Market: What You Need to Know - finance.yahoo.com
3 Wall Street Analysts Think Viking Therapeutics Stock Will Roughly Triple Over the Next 12 Months. Here's Why I Think They're Wrong - The Motley Fool
Viking Therapeutics to present at three major h... - Pluang
Viking Therapeutics to Participate at Upcoming Investor Conferences - PR Newswire
Viking Therapeutics Stock Is Down 66% From Its Peak. Here's What Comes Next. - The Motley Fool
Viking Therapeutics Stock (VKTX) Opinions on Phase 3 Obesity Drug Data Timing - quiverquant.com
6,189,649 Shares in Viking Therapeutics, Inc. $VKTX Purchased by BlackRock Inc. - InsuranceNewsNet
Viking Therapeutics Has $502 Million in Cash and 1 Big Catalyst Left in 2026 -- Is That Enough? - The Motley Fool
VKTX Stock Steady After-Hours On Positive Obesity Drug Pipeline Progress - Stocktwits
VKTX Stock Draws Fresh Attention Ahead Of Earnings: Wall Street Sees Over 170% Upside As GLP-1 Race Burns Hot - Stocktwits
VKTX Eyes Worst Week Since November As Trial Data Looms — Wall Street Still Sees 200% Upside - Stocktwits
A New GLP-1 Challenger? Early Data Shows Viking's New Obesity Drug Tops Novo Rival - Stocktwits
Viking Therapeutics (NASDAQ:VKTX) Upgraded to Hold at Zacks Research - MarketBeat
Viking Therapeutics (VKTX) Stock Still Looks Pricey With Pipeline Hopes Priced In - simplywall.st
Timothy G. Youngquist 2020 Irrevocable Trust Has $10.61 Million Position in Viking Therapeutics, Inc. $VKTX - MarketBeat
VKTX Stock Outpaces LLY, ALT Ahead Of Earnings – Retail Eyes Breakout Ahead - Stocktwits
Viking Therapeutics, Inc. Revenue Breakdown – NASDAQ:VKTX - TradingView
Viking Therapeutics Inc (VKTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
VKTX Stock Clocks Best Day In Nearly 3 Months On Obesity Pipeline Optimism, Buyout Speculation - stocktwits.com
Viking Therapeutics (VKTX) Edges Higher to $33.19 as Key Resistance Level Comes into FocusZero Gamma Level - Vinanet
Cornerstone Capital Inc. Takes $3.33 Million Position in Viking Therapeutics, Inc. $VKTX - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Viking Therapeutics Inc (VKTX) News, Articles, Events & Latest Updates - Stocktwits
0.28%
4.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):